vs

Side-by-side financial comparison of MEDIFAST INC (MED) and Velocity Financial, Inc. (VEL). Click either name above to swap in a different company.

MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $51.6M, roughly 1.5× Velocity Financial, Inc.). On growth, Velocity Financial, Inc. posted the faster year-over-year revenue change (32.8% vs -36.9%). Velocity Financial, Inc. produced more free cash flow last quarter ($17.9M vs $-6.6M). Over the past eight quarters, Velocity Financial, Inc.'s revenue compounded faster (32.3% CAGR vs -34.4%).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

Velocity Financial, Inc. is a U.S.-headquartered real estate finance company that offers specialized mortgage loan solutions primarily for residential investment properties. It partners with independent mortgage brokers nationwide, providing real estate investors with short-term bridge loans and long-term rental property financing options tailored to their operational needs.

MED vs VEL — Head-to-Head

Bigger by revenue
MED
MED
1.5× larger
MED
$75.1M
$51.6M
VEL
Growing faster (revenue YoY)
VEL
VEL
+69.7% gap
VEL
32.8%
-36.9%
MED
More free cash flow
VEL
VEL
$24.5M more FCF
VEL
$17.9M
$-6.6M
MED
Faster 2-yr revenue CAGR
VEL
VEL
Annualised
VEL
32.3%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MED
MED
VEL
VEL
Revenue
$75.1M
$51.6M
Net Profit
$34.8M
Gross Margin
69.4%
Operating Margin
-10.4%
97.0%
Net Margin
67.3%
Revenue YoY
-36.9%
32.8%
Net Profit YoY
67.0%
EPS (diluted)
$-1.64
$0.90

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
VEL
VEL
Q4 25
$75.1M
$51.6M
Q3 25
$89.4M
$49.1M
Q2 25
$105.6M
$47.6M
Q1 25
$115.7M
$37.5M
Q4 24
$119.0M
$38.9M
Q3 24
$140.2M
$35.1M
Q2 24
$168.6M
$32.4M
Q1 24
$174.7M
$29.5M
Net Profit
MED
MED
VEL
VEL
Q4 25
$34.8M
Q3 25
$-2.3M
$25.4M
Q2 25
$2.5M
$26.0M
Q1 25
$-772.0K
$18.9M
Q4 24
$20.8M
Q3 24
$1.1M
$15.8M
Q2 24
$-8.2M
$14.8M
Q1 24
$8.3M
$17.3M
Gross Margin
MED
MED
VEL
VEL
Q4 25
69.4%
Q3 25
69.5%
Q2 25
72.6%
Q1 25
72.8%
Q4 24
74.1%
Q3 24
75.4%
Q2 24
73.2%
Q1 24
72.8%
Operating Margin
MED
MED
VEL
VEL
Q4 25
-10.4%
97.0%
Q3 25
-4.6%
72.1%
Q2 25
-1.0%
71.3%
Q1 25
-1.1%
71.7%
Q4 24
0.6%
82.5%
Q3 24
1.5%
60.6%
Q2 24
-4.7%
61.3%
Q1 24
4.5%
78.8%
Net Margin
MED
MED
VEL
VEL
Q4 25
67.3%
Q3 25
-2.5%
51.7%
Q2 25
2.3%
54.6%
Q1 25
-0.7%
50.4%
Q4 24
53.5%
Q3 24
0.8%
45.1%
Q2 24
-4.8%
45.6%
Q1 24
4.8%
58.5%
EPS (diluted)
MED
MED
VEL
VEL
Q4 25
$-1.64
$0.90
Q3 25
$-0.21
$0.65
Q2 25
$0.22
$0.69
Q1 25
$-0.07
$0.51
Q4 24
$0.08
$0.56
Q3 24
$0.10
$0.44
Q2 24
$-0.75
$0.42
Q1 24
$0.76
$0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
VEL
VEL
Cash + ST InvestmentsLiquidity on hand
$167.3M
$92.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$198.9M
$672.5M
Total Assets
$248.0M
$7.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
VEL
VEL
Q4 25
$167.3M
$92.1M
Q3 25
$173.5M
$99.0M
Q2 25
$162.7M
$79.6M
Q1 25
$164.6M
$51.7M
Q4 24
$162.3M
$49.9M
Q3 24
$170.0M
$44.1M
Q2 24
$163.5M
$47.4M
Q1 24
$156.4M
$34.8M
Stockholders' Equity
MED
MED
VEL
VEL
Q4 25
$198.9M
$672.5M
Q3 25
$214.7M
$634.3M
Q2 25
$216.0M
$597.9M
Q1 25
$211.0M
$563.2M
Q4 24
$210.1M
$516.9M
Q3 24
$207.3M
$484.6M
Q2 24
$205.3M
$471.3M
Q1 24
$211.0M
$452.9M
Total Assets
MED
MED
VEL
VEL
Q4 25
$248.0M
$7.4B
Q3 25
$268.2M
$7.0B
Q2 25
$269.3M
$6.5B
Q1 25
$280.0M
$6.0B
Q4 24
$284.2M
$5.5B
Q3 24
$291.2M
$5.2B
Q2 24
$293.5M
$4.9B
Q1 24
$302.8M
$4.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
VEL
VEL
Operating Cash FlowLast quarter
$-5.3M
$18.2M
Free Cash FlowOCF − Capex
$-6.6M
$17.9M
FCF MarginFCF / Revenue
-8.8%
34.6%
Capex IntensityCapex / Revenue
1.8%
0.5%
Cash ConversionOCF / Net Profit
0.52×
TTM Free Cash FlowTrailing 4 quarters
$1.2M
$40.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
VEL
VEL
Q4 25
$-5.3M
$18.2M
Q3 25
$12.1M
$11.5M
Q2 25
$-3.4M
$7.7M
Q1 25
$3.4M
$3.5M
Q4 24
$-4.9M
$37.8M
Q3 24
$9.1M
$-17.6M
Q2 24
$13.1M
$11.5M
Q1 24
$7.3M
$10.6M
Free Cash Flow
MED
MED
VEL
VEL
Q4 25
$-6.6M
$17.9M
Q3 25
$10.8M
$11.4M
Q2 25
$-4.8M
$7.6M
Q1 25
$1.9M
$3.5M
Q4 24
$-7.2M
$37.5M
Q3 24
$7.7M
$-17.6M
Q2 24
$11.1M
$11.4M
Q1 24
$5.4M
$10.5M
FCF Margin
MED
MED
VEL
VEL
Q4 25
-8.8%
34.6%
Q3 25
12.0%
23.2%
Q2 25
-4.5%
15.9%
Q1 25
1.6%
9.2%
Q4 24
-6.1%
96.4%
Q3 24
5.5%
-50.3%
Q2 24
6.6%
35.1%
Q1 24
3.1%
35.8%
Capex Intensity
MED
MED
VEL
VEL
Q4 25
1.8%
0.5%
Q3 25
1.5%
0.1%
Q2 25
1.3%
0.2%
Q1 25
1.3%
0.2%
Q4 24
1.9%
0.7%
Q3 24
1.0%
0.2%
Q2 24
1.1%
0.3%
Q1 24
1.1%
0.1%
Cash Conversion
MED
MED
VEL
VEL
Q4 25
0.52×
Q3 25
0.45×
Q2 25
-1.36×
0.29×
Q1 25
0.19×
Q4 24
1.81×
Q3 24
8.04×
-1.11×
Q2 24
0.78×
Q1 24
0.88×
0.61×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MED
MED

Segment breakdown not available.

VEL
VEL

Related Party$19.3M37%
Nonrelated Party$16.9M33%
Other$15.4M30%

Related Comparisons